Subsequent Events

9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

Subsequent Events

8. Subsequent Events

Bio-Path entered into an agreement for drug substance manufacture of additional development batches for testing.  The Company also entered into an agreement with a testing firm for an additional new drug substance characterization assay.  In total, these projects will require Bio-Path to pay approximately $105,000 over a twelve month period.